927 related articles for article (PubMed ID: 26507447)
21. Concomitant psoriasis and bullous pemphigoid: coincidence or pathogenic relationship?
Wilczek A; Sticherling M
Int J Dermatol; 2006 Nov; 45(11):1353-7. PubMed ID: 17076725
[TBL] [Abstract][Full Text] [Related]
22. A case of bullous pemphigoid with IgG antibodies against LAD-1, but not BP180 NC16a domain or BP230.
Miyashita K; Iioka H; Miyagawa F; Ishii N; Hashimoto T; Asada H
Eur J Dermatol; 2018 Apr; 28(2):248-250. PubMed ID: 29378676
[No Abstract] [Full Text] [Related]
23. A case of generalized pustular psoriasis followed by bullous disease: an atypical case of bullous pemphigoid or a novel bullous disease?
Saeki H; Hayashi N; Komine M; Soma Y; Shimada S; Watanabe K; Hashimoto T
Br J Dermatol; 1996 Jan; 134(1):152-5. PubMed ID: 8745904
[TBL] [Abstract][Full Text] [Related]
24. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies to basement membrane proteins BP180 and BP230 are commonly detected in normal subjects by immunoblotting.
Desai N; Allen J; Ali I; Venning V; Wojnarowska F
Australas J Dermatol; 2008 Aug; 49(3):137-41. PubMed ID: 18638220
[TBL] [Abstract][Full Text] [Related]
26. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis.
Barnadas MA; Rubiales MV; González MJ; Puig L; García P; Baselga E; Pujol R; Alomar A; Gelpí C
Int J Dermatol; 2008 Dec; 47(12):1245-9. PubMed ID: 19126009
[TBL] [Abstract][Full Text] [Related]
27. Management of erythematous skin lesions in bullous pemphigoid associated with atopic dermatitis.
Kamiya K; Aoyama Y; Nishio E; Horio A; Tokura Y
J Dermatol; 2016 Sep; 43(9):1102-3. PubMed ID: 26946485
[No Abstract] [Full Text] [Related]
28. Assessment of Diagnostic Strategy for Early Recognition of Bullous and Nonbullous Variants of Pemphigoid.
Meijer JM; Diercks GFH; de Lang EWG; Pas HH; Jonkman MF
JAMA Dermatol; 2019 Feb; 155(2):158-165. PubMed ID: 30624575
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of IgG subclasses and complement deposition in BP230-type bullous pemphigoid.
Zheng M; Ujiie H; Iwata H; Muramatsu K; Yoshimoto N; Ito T; Ujiie I; Shimizu S; Sato-Matsumura KC; Shimizu H
J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):595-600. PubMed ID: 30394605
[TBL] [Abstract][Full Text] [Related]
30. Checkpoint Inhibition May Trigger the Rare Variant of Anti-LAD-1 IgG-Positive, Anti-BP180 NC16A IgG-Negative Bullous Pemphigoid.
Sadik CD; Langan EA; Grätz V; Zillikens D; Terheyden P
Front Immunol; 2019; 10():1934. PubMed ID: 31474998
[TBL] [Abstract][Full Text] [Related]
31. Paraneoplastic bullous pemphigoid: clinical disease activity correlated with enzyme-linked immunosorbent assay index for the NC16A domain of BP180.
Song HJ; Han SH; Hong WK; Lee HS; Shin JH; Choi GS
J Dermatol; 2009 Jan; 36(1):66-8. PubMed ID: 19207441
[No Abstract] [Full Text] [Related]
32. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid.
Yoshida M; Hamada T; Amagai M; Hashimoto K; Uehara R; Yamaguchi K; Imamura K; Okamoto E; Yasumoto S; Hashimoto T
J Dermatol Sci; 2006 Jan; 41(1):21-30. PubMed ID: 16364599
[TBL] [Abstract][Full Text] [Related]
33. Brunsting-Perry type localized bullous pemphigoid, possibly induced by furosemide administration and sun exposure.
TAKEICHI S; KUBO Y; ARASE S; HASHIMOTO T; ANSAI S
Eur J Dermatol; 2009; 19(5):500-3. PubMed ID: 19502152
[TBL] [Abstract][Full Text] [Related]
34. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
[TBL] [Abstract][Full Text] [Related]
35. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain.
Hofmann S; Thoma-Uszynski S; Hunziker T; Bernard P; Koebnick C; Stauber A; Schuler G; Borradori L; Hertl M
J Invest Dermatol; 2002 Nov; 119(5):1065-73. PubMed ID: 12445194
[TBL] [Abstract][Full Text] [Related]
36. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
Raffin D; Delaplace M; Roussel A; Estève E
Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
[TBL] [Abstract][Full Text] [Related]
37. Bullous Pemphigoid Masquerading as Erythema Annulare Centrifugum.
Yu-Yang S; Chu-Sung Hu S; Yiao-Lin S
Acta Dermatovenerol Croat; 2017 Oct; 25(3):255-256. PubMed ID: 29252183
[TBL] [Abstract][Full Text] [Related]
38. Anti-glomerular basement membrane nephritis and bullous pemphigoid caused by distinct anti-alpha 3(IV)NC1 and anti-BP180 antibodies in a patient with Crohn's disease.
Plaisier E; Borradori L; Hellmark T; Wattiaux MJ; Flageul B; Mougenot B; Ronco P
Am J Kidney Dis; 2002 Sep; 40(3):649-54. PubMed ID: 12200819
[TBL] [Abstract][Full Text] [Related]
39. [Bullous pemphigoid: diagnosis and therapy].
Kneisel A; Hertl M
Wien Med Wochenschr; 2014 Sep; 164(17-18):363-71. PubMed ID: 25077677
[TBL] [Abstract][Full Text] [Related]
40. Super-resolution imaging detects BP180 autoantigen in immunoglobulin M pemphigoid.
Hirano Y; Iwata H; Tsujuwaki M; Mai S; Mai Y; Imafuku K; Izumi K; Koga H; Ujiie H
J Dermatol; 2022 Mar; 49(3):374-378. PubMed ID: 34845743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
